Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase

Rosario Pivonello, Maria Fleseriu, John Newell-Price, Xavier Bertagna, James Findling, Akira Shimatsu, Feng Gu, Richard Auchus, Rattana Leelawattana, Eun Jig Lee, Jung Hee Kim, André Lacroix, Audrey Laplanche, Paul O'Connell, Libuse Tauchmanova, Alberto M. Pedroncelli, Beverly M.K. Biller

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase'. Together they form a unique fingerprint.

Agricultural and Biological Sciences

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science